Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004587106 | SCV005077143 | uncertain significance | not specified | 2024-04-19 | criteria provided, single submitter | clinical testing | Variant summary: VPS13B c.6097A>T (p.Ile2033Phe) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 250610 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.6097A>T in individuals affected with Cohen Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 991547). Based on the evidence outlined above, the variant was classified as uncertain significance. |
Natera, |
RCV001279773 | SCV001466894 | uncertain significance | Cohen syndrome | 2020-09-04 | no assertion criteria provided | clinical testing |